3D Interaction,drug ligand name,target,Uniprot code,n_ca_T,n_ca_M,n_local_pairs,local_rmsd,local_coverage,vendor,smiles,clinical_phase,moa,database,cids,target chain id,chain name,Align Length,Binding_Affinity_kcal/mol
2ITP_AEE_P62343.pdb,AEE,2ITP,P62343,306,524,78,0.681,0.255,Tocris,CCN1CCN(Cc2ccc(cc2)-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)CC1,Phase 1/Phase 2,EGFR inhibitor|VEGFR inhibitor,Uniprot,10297043,A,protein kinase [Plasmodium falciparum],238,-9.822
2ITT_AEE_Q6PLK2.pdb,AEE,2ITT,Q6PLK2,303,446,97,0.667,0.32,Tocris,CCN1CCN(Cc2ccc(cc2)-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)CC1,Phase 1/Phase 2,EGFR inhibitor|VEGFR inhibitor,Uniprot,10297043,A,protein kinase B-like protein [Plasmodium falciparum],212,-8.988
2ITT_AEE_P62343.pdb,AEE,2ITT,P62343,303,524,69,0.711,0.228,Tocris,CCN1CCN(Cc2ccc(cc2)-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)CC1,Phase 1/Phase 2,EGFR inhibitor|VEGFR inhibitor,Uniprot,10297043,A,protein kinase [Plasmodium falciparum],238,-9.638
2JIU_AEE_P62343.pdb,AEE,2JIU,P62343,303,524,107,0.687,0.353,Tocris,CCN1CCN(Cc2ccc(cc2)-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)CC1,Phase 1/Phase 2,EGFR inhibitor|VEGFR inhibitor,Uniprot,10297043,A,protein kinase [Plasmodium falciparum],238,-9.419
2J6M_AEE_P62343.pdb,AEE,2J6M,P62343,306,524,82,0.679,0.268,Tocris,CCN1CCN(Cc2ccc(cc2)-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)CC1,Phase 1/Phase 2,EGFR inhibitor|VEGFR inhibitor,Uniprot,10297043,A,protein kinase [Plasmodium falciparum],238,-9.749
